86 related articles for article (PubMed ID: 17229963)
1. Radiotherapy for prostate cancer.
Rutz HP; Lomax AJ
N Engl J Med; 2007 Jan; 356(3):308-9; author reply 310-1. PubMed ID: 17229963
[No Abstract] [Full Text] [Related]
2. Clinical stage T3 prostate cancer: the added value of three-dimensional conformal/intensity-modulated external-beam radiotherapy.
Bolla M
Eur Urol; 2008 Jun; 53(6):1104-6; discussion 1106-8. PubMed ID: 18295394
[No Abstract] [Full Text] [Related]
3. Radiotherapy for prostate cancer.
Elconin JH
N Engl J Med; 2007 Jan; 356(3):309-10; author reply 310-1. PubMed ID: 17240536
[No Abstract] [Full Text] [Related]
4. Intensity-modulated radiotherapy as primary therapy for prostate cancer: report on acute toxicity after dose escalation with simultaneous integrated boost to intraprostatic lesion.
Fonteyne V; Villeirs G; Speleers B; De Neve W; De Wagter C; Lumen N; De Meerleer G
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):799-807. PubMed ID: 18407430
[TBL] [Abstract][Full Text] [Related]
5. Medical memo: high-dose radiotherapy for prostate cancer.
Harv Mens Health Watch; 2007 Apr; 11(9):6. PubMed ID: 17441270
[No Abstract] [Full Text] [Related]
6. MRI before and after external beam intensity-modulated radiotherapy of patients with prostate cancer: the feasibility of monitoring of radiation-induced tissue changes using a dynamic contrast-enhanced inversion-prepared dual-contrast gradient echo sequence.
Franiel T; Lüdemann L; Taupitz M; Böhmer D; Beyersdorff D
Radiother Oncol; 2009 Nov; 93(2):241-5. PubMed ID: 19748143
[TBL] [Abstract][Full Text] [Related]
7. IMRT and molecular biological approaches in radiotherapy for prostate cancer.
Bristow RG
Eur J Cancer; 2009 Sep; 45 Suppl 1():429-30. PubMed ID: 19775659
[No Abstract] [Full Text] [Related]
8. Radiation management of prostate cancer.
Glicksman AS
Med Health R I; 2006 Feb; 89(2):74-5. PubMed ID: 16583666
[No Abstract] [Full Text] [Related]
9. Hypofractionated accelerated radiotherapy using concomitant intensity-modulated radiotherapy boost technique for localized high-risk prostate cancer: acute toxicity results.
Lim TS; Cheung PC; Loblaw DA; Morton G; Sixel KE; Pang G; Basran P; Zhang L; Tirona R; Szumacher E; Danjoux C; Choo R; Thomas G
Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):85-92. PubMed ID: 18355982
[TBL] [Abstract][Full Text] [Related]
10. Radiation-induced cancers from modern radiotherapy techniques: intensity-modulated radiotherapy versus proton therapy.
Yoon M; Ahn SH; Kim J; Shin DH; Park SY; Lee SB; Shin KH; Cho KH
Int J Radiat Oncol Biol Phys; 2010 Aug; 77(5):1477-85. PubMed ID: 19879701
[TBL] [Abstract][Full Text] [Related]
11. Is intensity-modulated radiotherapy for prostate cancer ready for prime-time?
Rodrigues G
Can J Urol; 2012 Aug; 19(4):6381-2. PubMed ID: 22892262
[No Abstract] [Full Text] [Related]
12. Hypofractionated intensity-modulated arc therapy for lymph node metastasized prostate cancer.
Fonteyne V; De Gersem W; De Neve W; Jacobs F; Lumen N; Vandecasteele K; Villeirs G; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1013-20. PubMed ID: 19386427
[TBL] [Abstract][Full Text] [Related]
13. Hypofractionated boost to the dominant tumor region with intensity modulated stereotactic radiotherapy for prostate cancer: a sequential dose escalation pilot study.
Miralbell R; Mollà M; Rouzaud M; Hidalgo A; Toscas JI; Lozano J; Sanz S; Ares C; Jorcano S; Linero D; Escudé L
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):50-7. PubMed ID: 19910135
[TBL] [Abstract][Full Text] [Related]
14. In regard to Trofimov et al.: Radiotherapy treatment of early-stage prostate cancer with IMRT and protons: a treatment planning comparison (Int J Radiat Oncol Biol Phys 2007;69:444-453).
Albertini F; Lomax AJ; Hug EB
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1333-4; author reply 1334-5. PubMed ID: 17967323
[No Abstract] [Full Text] [Related]
15. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter.
Vassiliev ON; Kry SF; Kuban DA; Salehpour M; Mohan R; Titt U
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1567-71. PubMed ID: 17544596
[TBL] [Abstract][Full Text] [Related]
16. Health-related quality of life in patients with locally advanced prostate cancer after 76 Gy intensity-modulated radiotherapy vs. 70 Gy conformal radiotherapy in a prospective and longitudinal study.
Lips I; Dehnad H; Kruger AB; van Moorselaar J; van der Heide U; Battermann J; van Vulpen M
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(3):656-61. PubMed ID: 17512127
[TBL] [Abstract][Full Text] [Related]
17. Intensity-modulated radiation therapy: supportive data for prostate cancer.
Cahlon O; Hunt M; Zelefsky MJ
Semin Radiat Oncol; 2008 Jan; 18(1):48-57. PubMed ID: 18082588
[TBL] [Abstract][Full Text] [Related]
18. Volumetric modulated arc therapy for delivery of prostate radiotherapy: in regard to Palma et al. (Int J Radiat Oncol Biol Phys 2008;70:996-1001).
Ost P; Fonteyne V; De Neve W; De Gersem W; De Wagter C; Vandecasteele K; Duprez F; De Meerleer G
Int J Radiat Oncol Biol Phys; 2009 Mar; 73(4):1286; author reply 1287. PubMed ID: 19251105
[No Abstract] [Full Text] [Related]
19. Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancer.
Zelefsky MJ; Yamada Y; Kollmeier MA; Shippy AM; Nedelka MA
Eur Urol; 2008 Jun; 53(6):1172-9. PubMed ID: 18222596
[TBL] [Abstract][Full Text] [Related]
20. A comparison of prostate IMRT and helical tomotherapy class solutions.
Rodrigues G; Yartsev S; Chen J; Wong E; D'Souza D; Lock M; Bauman G; Grigorov G; Kron T
Radiother Oncol; 2006 Sep; 80(3):374-7. PubMed ID: 16884799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
